TRPA1 promotes overactive bladder progression by activating the NLRP3 inflammasome and driving pyroptosis. [PDF]
Rao Y +6 more
europepmc +1 more source
Editorial Comment on: Use and Persistence of Beta-3 Adrenoceptor Agonists for the Treatment of Overactive Bladder. [PDF]
Mochizuki T.
europepmc +1 more source
Prevalence of and Factors Associated with Overactive Bladder, Anxiety, and Depression Among Patients with Multiple Sclerosis: A Cross-Sectional Study in Saudi Arabia. [PDF]
Alqwaifly M +9 more
europepmc +1 more source
Noninvasive NESA Microcurrent Neuromodulation for Refractory Overactive Bladder in Women: A Triple-Blind, Randomized, Sham-Controlled Pilot Trial. [PDF]
Conde-Santos G +7 more
europepmc +1 more source
Thread-Embedding versus Manual Acupuncture for Overactive Bladder in Postmenopausal Women: Randomized Controlled Trial. [PDF]
Choi SJ, Park JK.
europepmc +1 more source
A higher dietary inflammation index is associated with the incidence of overactive bladder: Evidence from a cross-sectional study (NHANES 2011-2018). [PDF]
Jin M, Huang Y, Lv X, Hao H, Luo M.
europepmc +1 more source
Prevalence and Trends in Overactive Bladder Among Women in the United States, 2005-2020. [PDF]
Xie H +5 more
europepmc +1 more source
Urethral Instability and Overactive Bladder Symptoms: Evidence From Clinical Practice. [PDF]
Freixo SD +3 more
europepmc +1 more source
Urothelial Proteome Changes Underlying Overactive Bladder Associated With Bladder Outlet Obstruction. [PDF]
Lee SY +8 more
europepmc +1 more source
Intravesical Botulinum Toxin Type A for an Overactive Bladder: A Single-Center Audit. [PDF]
Abolanle P +5 more
europepmc +1 more source

